Metabolic syndrome isn't just a heart risk. It's linked to some cancers.
People say: “Metabolic syndrome is a heart and metabolic risk” We read the study.
Meta-analysis of observational studies. 21 studies. 21 meta-analyses comprising 98 original observational studies; searches to 3 January 2023.
Many studies, added up. People were watched, not told what to do. A clue, not proof.
Who: Adults (18+) in any country in the original studies; 25 associations with obesity-related cancer risk and 5 with survival
- Colorectal cancer+41%highly suggestive
- Kidney cancer+67%highly suggestive
- Thyroid cancerunclearonly 2 studies
More to know, from our read of the paper:
- Observational evidence only (cohort, case-control, cross-sectional originals): linked, not proven. Unmeasured confounding, misclassification and reverse causation possible (authors)
- All 21 included meta-analyses were rated 'critically low' quality on AMSTAR 2 (mostly no protocol, no justification for exclusions); without those two criteria most rated moderate-high
- High heterogeneity in 18 of 25 risk associations (I2 > 50%); many different definitions of metabolic syndrome
- No association reached 'convincing' (class I) in main analyses; best = 'highly suggestive' (class II): colorectal (overall, men, women) and kidney. Renal moved to class I only in one sensitivity analysis
- Small-study effects/excess significance flagged for 8 of 25 risk and 3 of 5 survival associations
Linked to several cancers. Not yet proven.
This umbrella review pooled 21 earlier meta-analyses, covering 98 observational studies, on metabolic syndrome (high blood sugar, high blood pressure, unhealthy blood fats, belly fat) and obesity-related cancers. Metabolic syndrome was linked to 41% higher colorectal cancer risk and 67% higher kidney cancer risk, both rated 'highly suggestive' evidence. For thyroid and ovarian cancer there was no clear link, from only two studies each. All 21 reviews were rated critically low in quality and the data are observational: linked, not proven.
Winn M, Karra P, Benson R, Pauleck S, Chaiyakunapruk N, Khaing W, Veettil SK, McFarland MM, Casucci T, Xu Y, Hu-Lieskovan S, Litchman M, Playdon M, Hardikar S (2026). Metabolic Syndrome and Obesity-related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta-analysis of Observational Studies. Obesity Reviews.
Design: Meta-analysis of observational studies · umbrella review of 21 systematic reviews with meta-analysis of observational studies; summary effects re-estimated with random-effects models, evidence graded by modified Ioannidis criteria (linked, not proven)
DOI: 10.1111/obr.70073
Goals:
We read the abstract and the full text of this paper and checked every number on this page against it (17 facts, checked on 2026-10-29). The study design is named above. Cohort and other observational studies are described as linked, not proven. Found an error? Email theis@onestudyaday.com.
Join the waitlist: one checked study a day for your goal, by email
Pick up to three goals. We email you once when the daily study starts. The goals for this study are ticked already.